• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶酶体贮积症中的溶酶体生物发生

Lysosomal biogenesis in lysosomal storage disorders.

作者信息

Karageorgos L E, Isaac E L, Brooks D A, Ravenscroft E M, Davey R, Hopwood J J, Meikle P J

机构信息

Department of Chemical Pathology, Women's and Children's Hospital, North Adelaide, South Australia.

出版信息

Exp Cell Res. 1997 Jul 10;234(1):85-97. doi: 10.1006/excr.1997.3581.

DOI:10.1006/excr.1997.3581
PMID:9223373
Abstract

Lysosomal biogenesis is an orchestration of the structural and functional elements of the lysosome to form an integrated organelle and involves the synthesis, targeting, functional residence, and turnover of the proteins that comprise the lysosome. We have investigated lysosomal biogenesis during the formation and dissipation of storage vacuoles in two model systems. One involves the formation of sucrosomes in normal skin fibroblasts and the other utilizes storage disorder-affected skin fibroblasts; both of these systems result in an increase in the size and the number of lysosomal vacuoles. Lysosomal proteins, beta-hexosaminidase, alpha-mannosidase, N-acetylgalactosamine-4-sulfatase, acid phosphatase, and the lysosome-associated membrane protein, LAMP-1, were shown to be elevated between 2- and 28-fold above normal during lysosomal storage. Levels of mRNA for the lysosome-associated membrane proteins LAMP-1 and LAMP-2, N-acetylgalactosamine-4-sulfatase, and the 46- and 300-kDa mannose-6-phosphate receptors were also elevated 2- to 8-fold. The up-regulation of protein and mRNA lagged 2-4 days behind the formation of lysosomal storage vacuoles. Correction of storage, in both systems, resulted in the rapid decline of the mRNA to basal levels, with a slower decrease in the levels of lysosomal proteins. Lysosomal biogenesis in storage disorders is shown to be a regulated process which is partially controlled at, or prior to, the level of mRNA. Although lysosomal proteins were differentially regulated, the coordination of these events in lysosomal biogenesis would suggest that a common mechanism(s) may be in operation.

摘要

溶酶体生物发生是溶酶体的结构和功能元件的一种编排,以形成一个整合的细胞器,并且涉及构成溶酶体的蛋白质的合成、靶向、功能驻留和周转。我们在两个模型系统中研究了储存液泡形成和消散过程中的溶酶体生物发生。一个涉及正常皮肤成纤维细胞中蔗糖体的形成,另一个利用受储存障碍影响的皮肤成纤维细胞;这两个系统都会导致溶酶体液泡的大小和数量增加。溶酶体蛋白、β-己糖胺酶、α-甘露糖苷酶、N-乙酰半乳糖胺-4-硫酸酯酶、酸性磷酸酶以及溶酶体相关膜蛋白LAMP-1,在溶酶体储存期间显示比正常水平升高2至28倍。溶酶体相关膜蛋白LAMP-1和LAMP-2、N-乙酰半乳糖胺-4-硫酸酯酶以及46 kDa和300 kDa甘露糖-6-磷酸受体的mRNA水平也升高了2至8倍。蛋白质和mRNA的上调比溶酶体储存液泡的形成滞后2至4天。在这两个系统中,储存的纠正导致mRNA迅速下降至基础水平,溶酶体蛋白水平下降较慢。储存障碍中的溶酶体生物发生显示是一个受调控的过程,在mRNA水平或之前受到部分控制。尽管溶酶体蛋白受到不同的调控,但溶酶体生物发生中这些事件的协调表明可能存在一种共同机制在起作用。

相似文献

1
Lysosomal biogenesis in lysosomal storage disorders.溶酶体贮积症中的溶酶体生物发生
Exp Cell Res. 1997 Jul 10;234(1):85-97. doi: 10.1006/excr.1997.3581.
2
Regulation of the lysosome-associated membrane protein in a sucrose model of lysosomal storage.溶酶体贮积症蔗糖模型中溶酶体相关膜蛋白的调控
Exp Cell Res. 2000 Feb 1;254(2):204-9. doi: 10.1006/excr.1999.4755.
3
Altered trafficking and turnover of LAMP-1 in Pompe disease-affected cells.庞贝病影响的细胞中LAMP-1的转运和周转改变。
Mol Genet Metab. 1999 Mar;66(3):179-88. doi: 10.1006/mgme.1998.2800.
4
Roles of LAMP-1 and LAMP-2 in lysosome biogenesis and autophagy.LAMP-1和LAMP-2在溶酶体生物发生及自噬中的作用。
Mol Aspects Med. 2006 Oct-Dec;27(5-6):495-502. doi: 10.1016/j.mam.2006.08.005. Epub 2006 Sep 14.
5
The lysosomal-associated membrane protein LAMP-1 is a novel differentiation marker for HC11 mouse mammary epithelial cells.溶酶体相关膜蛋白LAMP-1是HC11小鼠乳腺上皮细胞的一种新型分化标志物。
Differentiation. 1996 Dec;61(2):113-20. doi: 10.1046/j.1432-0436.1996.6120113.x.
6
Estimation and comparison of lysosomal and cytoplasmic pH of human fibroblasts from healthy donors and patients with lysosomal storage diseases.健康供体和溶酶体贮积症患者的人成纤维细胞溶酶体和细胞质pH值的估计与比较。
Biomed Sci. 1991;2(4):398-402.
7
Lysosomal membrane proteins: life between acid and neutral conditions.溶酶体膜蛋白:酸性与中性环境之间的生存之道。
Biochem Soc Trans. 2010 Dec;38(6):1420-3. doi: 10.1042/BST0381420.
8
Pilot neonatal screening program for lysosomal storage disorders, using lamp-1.使用LAMP-1进行溶酶体贮积症的新生儿筛查试点项目。
Southeast Asian J Trop Med Public Health. 1999;30 Suppl 2:111-3.
9
Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.致癌基因诱导的溶酶体相关膜蛋白1和2下调对溶酶体细胞死亡途径的致敏作用。
Cancer Res. 2008 Aug 15;68(16):6623-33. doi: 10.1158/0008-5472.CAN-08-0463.
10
A potentially dynamic lysosomal role for the endogenous TRPML proteins.内源性TRPML蛋白潜在的动态溶酶体作用。
J Pathol. 2009 Oct;219(2):153-62. doi: 10.1002/path.2587.

引用本文的文献

1
GRASP55 regulates sorting and maturation of the lysosomal enzyme β-hexosaminidase A.GRASP55调节溶酶体酶β-己糖胺酶A的分选和成熟。
Mol Biol Cell. 2025 Mar 1;36(3):ar30. doi: 10.1091/mbc.E24-10-0452. Epub 2025 Jan 22.
2
Dysregulation of muscle cholesterol transport in amyotrophic lateral sclerosis.肌萎缩侧索硬化症中肌肉胆固醇转运的失调
Brain. 2025 Mar 6;148(3):788-802. doi: 10.1093/brain/awae270.
3
Identification of New Modulators and Inhibitors of Palmitoyl-Protein Thioesterase 1 for CLN1 Batten Disease and Cancer.
鉴定用于CLN1型贝敦氏病和癌症的新型棕榈酰蛋白硫酯酶1调节剂和抑制剂
ACS Omega. 2024 Feb 28;9(10):11870-11882. doi: 10.1021/acsomega.3c09607. eCollection 2024 Mar 12.
4
Advancing the Research and Development of Enzyme Replacement Therapies for Lysosomal Storage Diseases.推进溶酶体贮积症酶替代疗法的研发
GEN Biotechnol. 2022 Apr;1(2):156-162. doi: 10.1089/genbio.2021.0013. Epub 2022 Apr 20.
5
Nonretinoid chaperones improve rhodopsin homeostasis in a mouse model of retinitis pigmentosa.非视黄醇伴侣蛋白可改善色素性视网膜炎小鼠模型中的视紫红质动态平衡。
JCI Insight. 2022 May 23;7(10):e153717. doi: 10.1172/jci.insight.153717.
6
The p97 Inhibitor UPCDC-30245 Blocks Endo-Lysosomal Degradation.p97抑制剂UPCDC-30245阻断内溶酶体降解。
Pharmaceuticals (Basel). 2022 Feb 7;15(2):204. doi: 10.3390/ph15020204.
7
Biomarkers in Glycogen Storage Diseases: An Update.糖原贮积病中的生物标志物:最新进展
Int J Mol Sci. 2021 Apr 22;22(9):4381. doi: 10.3390/ijms22094381.
8
Adeno-associated virus serotype 1-based gene therapy for FTD caused by GRN mutations.基于腺相关病毒血清型 1 的基因治疗用于 GRN 突变引起的额颞叶痴呆。
Ann Clin Transl Neurol. 2020 Oct;7(10):1843-1853. doi: 10.1002/acn3.51165. Epub 2020 Sep 16.
9
The gene for the lysosomal protein LAMP3 is a direct target of the transcription factor ATF4.溶酶体蛋白 LAMP3 的基因是转录因子 ATF4 的直接靶标。
J Biol Chem. 2020 May 22;295(21):7418-7430. doi: 10.1074/jbc.RA119.011864. Epub 2020 Apr 20.
10
Chloroquine and bafilomycin A mimic lysosomal storage disorders and impair mTORC1 signalling.氯喹和巴弗洛霉素 A 模拟溶酶体储存障碍并损害 mTORC1 信号。
Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20200905.